NAUT · Nautilus Biotechnology Inc
United States · RS rating 85 · As of 2026-10-14
| Price | 2.16 USD |
|---|---|
| 1-day change | +5.4% |
| RS rating (overall / 1M / 3M / 12M) | 85 / 99 / 94 / 97 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 29 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +45.3% |
| Market cap (USD) | $326.5M |